HR 5623
117th Congress
House
Health
The Insulin Cost Reduction Act
Introduced: October 19, 2021
Introduced by:
Grothman, Glenn
Republican
· Wisconsin
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 20, 2021
Referred to the Subcommittee on Health.
Oct 19, 2021
Referred to the Subcommittee on Health.
Oct 19, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 19, 2021
Introduced in House
Plain-English summary
The Insulin Cost Reduction Act
This bill prohibits the negotiation of price concessions between insulin manufacturers and prescription drug plans under the Medicare prescription drug benefit unless the price concessions are either provided at the point of sale to beneficiaries or are reflected in cost-sharing requirements.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4
Cosponsors
1